RE:Let’s not jump the gun here Although I am on the same page as you when it comes to seeing the larger picture, timing is everything and the market mood that is prevailing makes this much more difficult to digest. We are banking on his skills to grow Tilray the same way he grew Hain as the founder of what became a front runner in the organic foods market. He certainly has a wealth of experience dealing with the complexities of a public company and bettering their market positions. He seems to be using the same roadmap that he used with Hain by acquiring new brands, without being able to borrow to finance Tilray's expansion, and so selling equity, at least for now, is really the only tool he has to improve the brand and grow sales by expanding into new markets. With Sweetwater he has his foot in the door for the day cannabis is fully legalised stateside Given all the regulatory barriers he has had to stickhandle in our Canadian market, he has experience that the MSO management have yet to face with the unknown in the US government's regulatory requirements.
On another note, The Globe and Mail has had a traditional rejection of anything cannabis and so a hit piece on anyone in that sector does not surprise me. After all, that sells "papers" or web hits and their advertisers' products. For that matter, our brains are wired to react to what we find threatening and we have what is known as negativity bias. G&M certainly are not alone in gearing those negative stories to drive participation. Bloomberg is rife with negative stories and one could pretty well apply this to most information sites that sell advertising, such as Yahoo.
In the end, anyone who has invested in Tilray needs to take a serious look at why they are and decide what they as an individual are prepared to accept. I certainly am not happy when I see my dwindling resources, especially since I have been invested since 2016 and have had many bumps on the road to contend with. Also, I am not saying that the $30mil that was awarded to him should not come under scrutiny. Indeed we as shareholders have the right and obligation to question decisions that are made that ultimately affect our investment. To quote Teddy Roosevelt “Nothing in the world is worth having or worth doing unless it means effort, pain, and difficulty.” Give Simon time to prove Tilray is worth having in your portfolio and to manifest his vision, despite the effort, pain and difficulty. .
glta